Literature DB >> 19961963

Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART.

Silvana D Pessoa1, Maristela Miyamoto, Erika Ono, Aída F T B Gouvêa, Maria Isabel de Moraes-Pinto, Regina C M Succi.   

Abstract

Humoral immune response to vaccine antigens is known to be reduced in perinatally HIV-infected children. Lymphocyte immunophenotyping, humoral immunity to hepatitis B after primary immunization and response to revaccination were evaluated in 40 HIV-infected adolescents on HAART and 23 healthy age-matched controls. Anti-HBs antibody levels >or=10 mIU/mL were found in 18/40 (40.5%) of the HIV-infected adolescents and 18/23 (78.3%) of the HIV-negative adolescents from Control group. Adolescents of HIV group with anti-HBs>or=1 0 mIU/mL presented a higher CD4+ T cell percentage, higher naïve and central memory CD8+ T cell percentages and lower immune activation markers. After revaccination, 12/18 (66.7%) adolescents of HIV group responded. Those adolescents who did not respond to revaccination presented a lower CD4+ T cell percentage, higher immune activation markers and more frequently detectable HIV viral load. We concluded that lower immune activation, higher CD4+ T cell percentage and better control of HIV replication may be associated with hepatitis B vaccine response. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961963     DOI: 10.1016/j.vaccine.2009.11.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV.

Authors:  Priya D Farooq; Kenneth E Sherman
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

Review 2.  Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.

Authors:  Solen Kernéis; Odile Launay; Clément Turbelin; Frédéric Batteux; Thomas Hanslik; Pierre-Yves Boëlle
Journal:  Clin Infect Dis       Date:  2014-01-10       Impact factor: 9.079

Review 3.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

4.  Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Robert J O'Connell; Helen M Chun; Anuradha Ganesan; Jason F Okulicz; Tahaniyat Lalani; Amy C Weintrob; Nancy F Crum-Cianflone; Brian K Agan
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

5.  Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders.

Authors:  Mahsa Eshkevar Vakili; Zahra Faghih; Jamal Sarvari; Mehrnoosh Doroudchi; Seyed Nezamedin Hosseini; Dieter Kabelitz; Kurosh Kalantar
Journal:  Immunol Res       Date:  2022-04-20       Impact factor: 4.505

6.  Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.

Authors:  Houda Haban; Soumia Benchekroun; Mina Sadeq; Abdelaziz Benjouad; Said Amzazi; Hicham Oumzil; Elmir Elharti
Journal:  BMC Public Health       Date:  2017-09-29       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.